FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034685714> ?p ?o ?g. }

• W2034685714 endingPage "27508" @default.
• W2034685714 startingPage "27505" @default.
• W2034685714 abstract "Receptor-like protein-tyrosine phosphatases (RPTPs) play important roles in regulating intracellular processes. We have been investigating the regulation and function of RPTPμ, a receptor-like PTP related to the Ig superfamily of cell adhesion molecules. Recently, the crystal structure of a dimer of the membrane proximal domain of RPTPα (RPTPα D1) was described (Bilwes, A. M., den Hertog, J., Hunter, T., and Noel J. P. (1996)Nature 382, 555–559). Within this crystal structure, the catalytic site of each subunit of the dimer is sterically blocked by the insertion of the N-terminal helix-turn-helix segment of the dyad-related monomer. It was proposed that dimerization would lead to inhibition of catalytic activity and may provide a paradigm for the regulation of the RPTP family. We have determined the crystal structure, to 2.3 Å resolution, of RPTPμ D1, which shares 46% sequence identity with that of RPTPα D1. Although the tertiary structures of RPTPα D1 and RPTPμ D1 are very similar, with a root mean square deviation between equivalent Cα atoms of 1.1 Å, the quaternary structures of these two proteins are different. Neither the catalytic site nor the N-terminal helix-turn-helix segment of RPTPμ D1 participates in protein-protein interactions. The catalytic site of RPTPμ D1 is unhindered and adopts an open conformation similar to that of the cytosolic PTP, PTP1B (Barford, D., Flint, A. J., and Tonks, N. K. (1994) Science 263, 1397–1404). We propose that dimerization-induced modulation of RPTP activity may not be a general feature of this family of enzymes. Receptor-like protein-tyrosine phosphatases (RPTPs) play important roles in regulating intracellular processes. We have been investigating the regulation and function of RPTPμ, a receptor-like PTP related to the Ig superfamily of cell adhesion molecules. Recently, the crystal structure of a dimer of the membrane proximal domain of RPTPα (RPTPα D1) was described (Bilwes, A. M., den Hertog, J., Hunter, T., and Noel J. P. (1996)Nature 382, 555–559). Within this crystal structure, the catalytic site of each subunit of the dimer is sterically blocked by the insertion of the N-terminal helix-turn-helix segment of the dyad-related monomer. It was proposed that dimerization would lead to inhibition of catalytic activity and may provide a paradigm for the regulation of the RPTP family. We have determined the crystal structure, to 2.3 Å resolution, of RPTPμ D1, which shares 46% sequence identity with that of RPTPα D1. Although the tertiary structures of RPTPα D1 and RPTPμ D1 are very similar, with a root mean square deviation between equivalent Cα atoms of 1.1 Å, the quaternary structures of these two proteins are different. Neither the catalytic site nor the N-terminal helix-turn-helix segment of RPTPμ D1 participates in protein-protein interactions. The catalytic site of RPTPμ D1 is unhindered and adopts an open conformation similar to that of the cytosolic PTP, PTP1B (Barford, D., Flint, A. J., and Tonks, N. K. (1994) Science 263, 1397–1404). We propose that dimerization-induced modulation of RPTP activity may not be a general feature of this family of enzymes. Numerous cellular events are regulated by reversible phosphorylation of tyrosine residues, including growth, differentiation, the cell cycle, cell-cell adhesion, and cell-matrix contacts (1Neel B.G. Tonks N.K. Curr. Opin. Cell Biol. 1997; 9: 193-204Crossref PubMed Scopus (741) Google Scholar). Phosphotyrosine levels are controlled by the coordinated and competing actions of protein-tyrosine kinases and protein-tyrosine phosphatases (PTPs). 1The abbreviations used are: PTP, protein-tyrosine phosphatases; RPTP, receptor protein-tyrosine phosphatase; D1, domain 1 (membrane proximal domain) of RPTPs; DTT, dithiothreitol; NCS, noncrystallographic symmetry. The PTPs comprise a diverse family of transmembrane receptor-like and nontransmembrane, cytosolic enzymes (1Neel B.G. Tonks N.K. Curr. Opin. Cell Biol. 1997; 9: 193-204Crossref PubMed Scopus (741) Google Scholar). Receptor-like PTPs are likely to play crucial roles in transducing transmembrane signals and evidence is accumulating to link these enzymes to the control of phenomena mediated by cell adhesion (1Neel B.G. Tonks N.K. Curr. Opin. Cell Biol. 1997; 9: 193-204Crossref PubMed Scopus (741) Google Scholar). By interacting with ligands through their extracellular domains, the intracellular catalytic activity of RPTPs may be regulated, hence controlling the levels of cellular phosphotyrosine. The receptor-like PTPs RPTPμ, RPTPκ, and RPTPλ, which have extracellular segments sharing structural similarities with Ig superfamily cell adhesion molecules, have been shown to mediate cell aggregation via homophilic interactions (2Brady-Kalnay S.M. Flint A.J. Tonks N.K. J. Cell Biol. 1993; 122: 961-972Crossref PubMed Scopus (242) Google Scholar, 3Sap J.Y Jiang Y.P. Friedlander D. Grumet M. Schlessinger J. Mol. Cell. Biol. 1994; 14: 1-9Crossref PubMed Google Scholar, 4Cheng J. Wu K. Armanini M.O. Rourke N. Dowbenko D. Lasky L.A. J. Biol. Chem. 1997; 272: 7264-7277Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar). For RPTPμ, the homophilic binding site(s) reside on the immunoglobulin domain, whereas the intracellular segment consists of a juxtamembrane, cadherin-like domain, and two PTP domains (5Brady-Kalnay S.M. Tonks N.K. J. Biol. Chem. 1994; 269: 28472-28477Abstract Full Text PDF PubMed Google Scholar). A role for RPTPμ in regulating cell junctions and cytoskeletal organization is suggested by the finding that the RPTPμ is associated with cadherin-catenin complexes at adherens junctions (6Brady-Kalnay S.M. Rimm D.L. Tonks N.K. J. Cell Biol. 1995; 130: 977-986Crossref PubMed Scopus (287) Google Scholar). Similar results have been demonstrated for RPTPκ (7Fuchs M. Muller T. Lerch M.M. Ullrich A. J. Biol. Chem. 1996; 271: 16712-16719Abstract Full Text Full Text PDF PubMed Scopus (181) Google Scholar) and RPTPλ (4Cheng J. Wu K. Armanini M.O. Rourke N. Dowbenko D. Lasky L.A. J. Biol. Chem. 1997; 272: 7264-7277Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar). The crystal structure of PTP1B in a complex with a phosphotyrosyl peptide substrate (8Jia Z. Barford D. Flint A.J. Tonks N.K. Science. 1995; 268: 1754-1758Crossref PubMed Scopus (559) Google Scholar), together with the results of a number of kinetic studies (9Denu J.M. Stuckey J.A. Saper M.A. Dixon J.E. Cell. 1996; 87: 361-364Abstract Full Text Full Text PDF PubMed Scopus (306) Google Scholar), have revealed important insights into the catalytic mechanism of members of the PTP family. The signature motif, (I/V)HCXAGXXR(S/T)G, which defines this family of enzymes, contains the catalytically essential Cys and Arg residues. It forms a rigid cradle structure that coordinates binding of the phosphate moiety of the substrate and positions the cysteine residue to act as a nucleophile. This motif lies at the base of a cleft on the surface of the enzyme, which is defined at one end by the invariant residue Tyr46 and at the other by Phe182, which is in a loop containing the invariant general acid Asp181within the highly conserved motif WPD. It is the depth of the cleft, equivalent to the length of a phosphotyrosine side chain, that is a major determinant of the specificity of these enzymes for Tyr(P) substrates, since the side chains of Ser(P) and Thr(P) are too short to permit access of the phosphate to the catalytic cysteine. Binding of substrate induces a profound conformational change in the enzyme such that on engagement of Tyr(P) the WPD loop flips down onto the Tyr(P) side chain (8Jia Z. Barford D. Flint A.J. Tonks N.K. Science. 1995; 268: 1754-1758Crossref PubMed Scopus (559) Google Scholar). This creates a predominantly hydrophobic recognition pocket that surrounds and interacts with the phenyl ring of the Tyr(P) side chain and allows Asp181 to act as a catalytic acid. Catalysis proceeds via nucleophilic attack by the invariant Cys (Cys215) on the substrate phosphorous atom and protonation of the tyrosyl-leaving group of the substrate by Asp181resulting in formation of a cysteinyl-phosphate covalent intermediate. The reaction is then completed by hydrolysis of the covalent intermediate by a water molecule, possibly activated by Asp181 (10Denu J.M. Lohse D.L. Vijayalakshmi J. Saper M.A. Dixon J.E. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 2493-2498Crossref PubMed Scopus (252) Google Scholar). Recently, a model for the regulation of RPTP activity was proposed by Bilwes et al. (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar) on the basis of their crystal structure of domain 1 of RPTPα. In contrast to the cytosolic PTPs, PTP1B andYersinia PTP, which are monomeric (12Barford D. Flint A.J. Tonks N.K. Science. 1994; 263: 1397-1404Crossref PubMed Scopus (688) Google Scholar, 13Stuckey J.A. Schubert H.L. Fauman E.B. Zhang Z.-Y. Dixon J.E. Saper M.A. Nature. 1994; 370: 571-575Crossref PubMed Scopus (379) Google Scholar), the crystal structure of domain 1 (D1) of RPTPα revealed a homodimeric organization that would result in an inhibited PTP (8Jia Z. Barford D. Flint A.J. Tonks N.K. Science. 1995; 268: 1754-1758Crossref PubMed Scopus (559) Google Scholar, 11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar). The dimer results from a structural segment at the N terminus of the RPTPα D1 catalytic domain, consisting of a turn connecting helices α1′ and α2′ that wedges into the dyad-related catalytic site. The insertion of residues of the helix-turn-helix segment of one subunit into the catalytic site of the dyad-related subunit would be predicted to inhibit catalytic activity. This occurs first, as a result of sterically blocking substrate access to the catalytic site, and second, by constraining the WPD loop in an open conformation that is unable to adopt the closed conformation necessary for catalysis (8Jia Z. Barford D. Flint A.J. Tonks N.K. Science. 1995; 268: 1754-1758Crossref PubMed Scopus (559) Google Scholar). Distinct features of tertiary structure of RPTPα D1 that are absent from PTP1B are thought to facilitate this dimeric interaction. These include first, a two-residue insertion in the loop connecting α1′ and α2′, that inserts into the dyad-related catalytic site, and second, a β-strand (βx), immediately N-terminal to α1′ that forms a distinctive two-strand β-sheet with βy. The β-sheet between βx and βy, together with conserved residues within α1′ and α2′, contribute to defining the conformation of the helix-turn-helix segment of RPTPα D1 (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar). Interestingly, a sequence analysis of the PTP family suggested, on the basis of residue conservations, that the tertiary structural features of RPTPα D1 would be shared with D1s of other RPTPs but not cytosolic PTPs, such as PTP1B, or D2 of RPTPs (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar). The crystal structure of RPTPα D1 lead Bilwes et al. (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar) to propose a dimerization model for the regulation of RPTPα and, as a result of the sequence similarity with other RPTP D1s, it was suggested that this model could provide a paradigm for the regulation of RPTPs generally (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar). The model proposes that ligand binding to the extracellular segment would modulate dimerization and hence the catalytic activity of the PTP domain. We have been pursuing an investigation of the function of the Ig superfamily cell adhesion molecule related-phosphatase RPTPμ. At present little is known about the regulation of RPTPμ activity. Although it associates through its intracellular segment with the cadherin-catenin complex (6Brady-Kalnay S.M. Rimm D.L. Tonks N.K. J. Cell Biol. 1995; 130: 977-986Crossref PubMed Scopus (287) Google Scholar), the effects on PTP activity remain unclear. We have initiated a structural analysis of RPTPμ to provide further insights into the mechanisms for control of its enzymatic activity. In this regard, the possibility that the structure of RPTPα is indicative of a general mechanism for ligand-induced inhibition of RPTP activity is exciting. Here, we describe the crystal structure of domain 1 of human RPTPμ and show that although it is present in the crystal as a dimer, unlike RPTPα D1, the active site of RPTPμ is in an open, uninhibited conformation. Therefore our data indicate that regulation of RPTP activity by dimerization is not a general feature of these enzymes. Residues 874–1168 of human RPTPμ D1 were cloned into a modified version of the pET28a vector (Novagen Inc.) 2D. Barford and N. Hanlon, unpublished data. that incorporates an N-terminal hexa-His tag immediately preceding Gly874. The protein was overexpressed in Escherichia coli (strain B834) grown at 18 °C for 16 h. Protein purification was achieved with the following steps. Bacterial cells were lysed in 25 mm Tris·HCl (pH 8.0), 500 mmNaCl, 20 mm imidazole, 2 mm benzamidine, 0.01 mm phenylmethylsulfonyl fluoride, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 1 μg/ml pepstatin, 1 μg/ml DNase, 5 μg/ml lysozyme and the cleared lysate loaded onto a nickel-nitrilotriacetic acid-agarose column (Novagen Inc.) equilibrated in 50 mmTris·HCl (pH 8.0), 500 mm NaCl, 2 mmbenzamidine, and 20 mm imidazole. RPTPμ D1 was eluted using 50 mm imidazole. Peak fractions were dialyzed against a buffer of 25 mm Tris·HCl (pH 8.0), 50 mmNaCl, 2 mm DTT, 2 mm EDTA, 2 mmbenzamidine. Precipitated impurities where removed by centrifugation and the filtered solution loaded onto a Mono Q column (Pharmacia Biotech Inc.) equilibrated in dialysis buffer. RPTPμ D1 was collected in the flow-through, brought to 1.0 m ammonium sulfate, and applied to a phenyl TSK column (TosoH Corp.) equilibrated in 1.0m ammonium sulfate, 25 mm Tris·HCl (pH 8.0), 50 mm NaCl, 2 mm EDTA, 2 mm DTT, 2 mm benzamidine. The enzyme was eluted by applying a linear gradient of 300 ml to a buffer of 25 mm Tris·HCl (pH 8.0), 50 mm NaCl, 2 mm EDTA, 2 mmDTT, 2 mm benzamidine. Peak fractions were loaded onto a Superdex 75 gel filtration column (Pharmacia Biotech Inc.). The protein, at greater that 99% purity, was concentrated to 7.5 mg/ml and crystallized at 4 °C in conditions of 750 mm sodium citrate (pH 5.5), 2 mm DTT, 0.5 mm EDTA. 100 μl of RPTPμ D1 at 7.5 mg/ml was loaded onto a Superdex 75 prep gel filtration column (Pharmacia Biotech Inc.) equilibrated with 50 mm Tris·HCl (pH 7.5), 200 mm NaCl and run at a flow rate of 1 ml/min. X-ray crystallographic data were collected to 2.3-Å resolution and processed using DENZO and SCALEPACK (14Otwinowski Z. Sawyer L. Isaacs N. Bailey S. Data Collection and Processing. Science and Engineering Research Council, Daresbury Laboratory, Warrington, UK1993Google Scholar). The structure was determined by molecular replacement using the CCP4 integrated version of AMoRe (15Navaza J. Acta Crystallogr. Sec. A. 1994; 50: 157-163Crossref Scopus (5030) Google Scholar, 16Collaborative Computer Project No. 4 Acta Crystallogr. Sec. D. 1994; 50: 760-763Crossref PubMed Scopus (19797) Google Scholar) using a polyalanine model of RPTPα (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar), including side chains of residues identical with those of RPTPμ, as a search model. Crystallographic refinement was performed using X-PLOR (17Brunger A.T. X-PLOR, Version 3.1. Yale University Press, New Haven, CT1992Google Scholar), applying strict noncrystallographic symmetry (NCS) restraints. Calculated phases using the model were improved by several cycles of combined solvent flattening (solvent content 0.50) and NCS averaging using the PHASES package (18Furey W. Swaminathan S. Am. Crystallogr. Assoc. Meet. Summ. 1990; 18: 73Google Scholar). Iterative rounds of simulated annealing refinement, combined with NCS averaging and solvent flattening, were applied to improve the quality of the maps and the protein model. During the final stages of refinement, the NCS restraints were removed. Analysis of the coordinates and electron density maps was performed with O (19Jones T.A. Zou J. Cowan S.W. Kjeldgaard M. Acta Crystallogr. Sec. A. 1991; 47: 110-119Crossref PubMed Scopus (13014) Google Scholar). The final model consists of residues 879–1156 of RPTPμ D1 that are visible within the electron density and 340 water molecules (TableI). The structure of RPTPα D1 consists of residues 877–1156 (RPTPμ numbering (20Gebbink M. Van Etten I. Hateboer G. Suijkerbuijk R. Beijersbergen R. Van Kessel A. Moolenar W. FEBS Lett. 1991; 290: 123-130Crossref PubMed Scopus (110) Google Scholar)).Table ICrystallographic data and refinement statisticsCrystallographic data: Space groupP21 Cell parametersa = 95.54 Å, b = 36.29 Å, c = 95.38 Å, β = 95.66° Z2 X-ray sourcePX 7.2, SRS, Daresbury Resolution50 to 2.3 Å Observations (n)112,065 Unique reflections (complete)26,733 (89.5%) R sym1-aR sym: Σ h Σ i ‖I ( h ) −I i ( h )‖/Σ h Σ i I i ( h ), where I i ( h ) andI ( h ) are the ith and mean measurement of reflection h.0.030 I/sigI21.2Refinement statistics: Resolution8.0 to 2.3 Å Number of reflections (complete)25,566 (90%) Protein atoms (n)5,460 Water molecules (n)340 R cryst (work/free)1-bR cryst: Σ h ‖F o −F c ‖/Σ h F o, whereF o and F c are the observed and calculated structure factor amplitudes of reflection h.0.195/0.26 R.m.s.d. bond lengths0.008 Å R.m.s.d. bond angles1.39°1-a R sym: Σ h Σ i ‖I ( h ) −I i ( h )‖/Σ h Σ i I i ( h ), where I i ( h ) andI ( h ) are the ith and mean measurement of reflection h.1-b R cryst: Σ h ‖F o −F c ‖/Σ h F o, whereF o and F c are the observed and calculated structure factor amplitudes of reflection h. Open table in a new tab In the crystal structure of RPTPμ D1, the subunits associate to form a dimer with 2-fold symmetry (Fig.1). It is most likely that the dimerization of RPTPμ D1 is a consequence of crystallization, since size exclusion chromatography studies revealed that the protein was monomeric with an apparent molecular mass of ∼28 kDa in concentrated solutions of ∼7.5 mg/ml (Fig. 2). This is in contrast to RPTPα D1, which forms monomers, dimers, and higher oligomers in solution at protein concentrations of 0.1–5.0 mg/ml (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar). The oligomeric state of RPTPμ D1 is entirely different from that of RPTPα D1, since the dimer interface of RPTPμ D1 does not include the N-terminal helix-turn-helix segment or the catalytic site (Fig. 1). Crystal packing analysis also shows no obstruction of the catalytic site of RPTPμ D1. The interactions between the two dimeric subunits of RPTPμ are hydrophobic in nature and mediated by residues Thr1025 and Ile1027 from one subunit and residue Ile1050 and the aliphatic moeity of Glu1052 from the other. These residues are not conserved within other RPTPs (Fig. 3). Within RPTPμ D1, the catalytic site is unhindered and adopts an open conformation similar to that of the apo form of PTP1B (12Barford D. Flint A.J. Tonks N.K. Science. 1994; 263: 1397-1404Crossref PubMed Scopus (688) Google Scholar). Residues of RPTPμ, equivalent to those of the RPTPα helix-turn-helix that inserts into the dyad related catalytic site, are exposed to solvent (Fig. 1).Figure 2Size-exclusion chromatography indicating that RPTPμ D1 elutes as a monomeric species with an apparent molecular mass of 28 kDa. Molecular mass markers used are: dextran blue (200 kDa), bovine serum albumin (66 kDa), carbonic anhydrase (29 kDa), and cytochrome c (12.4 kDa).View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 3Sequence alignment of representative RPTP D1s in the regions that form the dimer interfaces of RPTPα and RPTPμ. Top left, βx-helix-turn-helix segment; top right, residues of the Tyr(P) recognition loop of the catalytic site. Bottom, residues from β8 through to the WPD loop of the catalytic site. Residues of RPTPμ D1 and RPTPα D1 that form interactions at their respective dimer interfaces are indicated withvertical arrows (top) and stars(bottom), respectively. The residues that form the dimer interface of RPTPμ D1 are poorly conserved throughout the family, whereas residues of the RPTPα D1 interface are poorly conserved within the helix-turn-helix segment, but well conserved within the catalytic site. Invariant residues are in white type on ablack background, and highly conserved residues areboxed.View Large Image Figure ViewerDownload Hi-res image Download (PPT) In contrast to the differences in quaternary structure between RPTPα and RPTPμ, the tertiary structures of domain 1 of these two RPTPs are very similar with a root mean square deviation between equivalent Cα atoms of 1.1 Å after superimposition (Fig.4). The major differences in tertiary structure are present within more mobile surface loops. Of particular note, the tertiary arrangements of the N-terminal helix-turn-helix segment and N-terminal β-strand, βx, and associated β-sheet with βy, of RPTPμ are essentially identical to that of the equivalent structural elements of RPTPα. These features distinguish RPTP D1s from the catalytic domains and N-terminal flanking sequences of cytosolic PTPs and are important in promoting the dimeric organization of RPTPα D1. Interestingly, Asp227 and Asp228of RPTPα D1, which are present within the helix-turn-helix segment that inserts into the dyad-related catalytic site, superimpose less well with equivalent residues of RPTPμ D1 (Ala895 and Glu896, respectively). The Cα atoms of these residues differ by 1.8 Å after global superimposition (Fig. 4), although this region of the polypeptide chain is well ordered. Among RPTPs, conservation of amino acids within the N-terminal helix-turn-helix that contribute to the dimer interface of RPTPα D1 is low (Fig. 3). Of the five residues implicated in this dimeric interface, only Glu234 is conserved between RPTPμ D1 and RPTPα D1. However, catalytic site residues that form the dimer interface of RPTPα D1 are either invariant or highly conserved between different RPTPs (Fig. 3). Thus, it is unlikely that invariant catalytic site residues would have the potential to interact with all of the structurally diverse N-terminal helix-turn-helix segments within the RPTP family. Moreover, if this were possible, it would imply that RPTP heterodimers may form as the catalytic sites of any given RPTP would not distinguish between the helix-turn-helix segments of other RPTPs. The structure of D1 of RPTPα determined by Bilwes et al.(11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar) indicated the existence of a dimer in which a helix-turn-helix segment on the N-terminal side of one catalytic domain occupied the catalytic site of the opposing PTP domain in the dimer. This observation led the authors to propose the exciting possibility that ligand-induced dimerization of RPTPs in general may lead to inhibition of activity. They used this structural model to interpret previous observations regarding the signaling properties of an EGF receptor-CD45 chimera (21Desai D.M. Sap J. Schlessinger J. Weiss A. Cell. 1993; 73: 541-554Abstract Full Text PDF PubMed Scopus (244) Google Scholar). Ablation of expression of CD45, the prototypic RPTP, from T or B cells disrupts normal signaling responses to engagement of antigen receptor. However, in some T cell lines, signaling can be restored by expression of membrane-targeted constructs containing the catalytic domain of CD45. In the instance of the chimeric molecule in which the extracellular and transmembrane segments of CD45 were replaced with those of the EGF receptor, signaling was restored only in the absence of EGF. It was proposed that in the presence of growth factor, dimerization of the chimera is induced with resulting inhibition of PTP activity. However, a direct effect of ligand binding on the catalytic activity of the EGFR-CD45 chimera has not been reported. Our results suggest caution in extrapolating beyond the structure of RPTPα to other RPTPs. We show that the N-terminal helix-turn-helix of RPTPμ D1 does not cause formation of an inhibited dimeric state, similar to that of RPTPα D1 (11Bilwes M. den Hertog J. Hunter T. Noel J.P. Nature. 1996; 382: 555-559Crossref PubMed Scopus (292) Google Scholar), and therefore the dimeric structure of RPTPα D1 may not represent the situation for all members of the RPTP family. Dimerization may be a feature of only a subfamily of RPTPs, such as RPTPα and its close relatives, for example CD45, which share sequence similarity in those residues participating at the N-terminal helix-turn-helix dimer interface (Fig.3). Our results do not exclude the possibility that in the context of the plasma membrane the full-length form of RPTPμ may form an inhibited dimer. However, the fact we do not observe dimers of RPTPμ D1 in solution, unlike that for RPTPα D1, and that within the RPTPμ D1 crystal, which would mimic the restricted diffusion of RPTPμ in the plasma membrane, inhibition of catalytic sites is not observed, suggests that the N-terminal helix-turn-helix of RPTPμ D1 does not play a role in regulating the activity of this phosphatase." @default.
• W2034685714 created "2016-06-24" @default.
• W2034685714 creator A5005973308 @default.
• W2034685714 creator A5087932715 @default.
• W2034685714 creator A5089377691 @default.
• W2034685714 date "1997-10-01" @default.
• W2034685714 modified "2023-09-30" @default.
• W2034685714 title "The Crystal Structure of Domain 1 of Receptor Protein-tyrosine Phosphatase μ" @default.
• W2034685714 cites W1504159440 @default.
• W2034685714 cites W2001641653 @default.
• W2034685714 cites W2013083986 @default.
• W2034685714 cites W2016954161 @default.
• W2034685714 cites W2028231353 @default.
• W2034685714 cites W2035791896 @default.
• W2034685714 cites W2044529125 @default.
• W2034685714 cites W2059452371 @default.
• W2034685714 cites W2064426988 @default.
• W2034685714 cites W2066641929 @default.
• W2034685714 cites W2080476827 @default.
• W2034685714 cites W2085634797 @default.
• W2034685714 cites W2087335054 @default.
• W2034685714 cites W2090236692 @default.
• W2034685714 cites W2093634504 @default.
• W2034685714 cites W2153343124 @default.
• W2034685714 cites W2159102915 @default.
• W2034685714 cites W2164240843 @default.
• W2034685714 doi "https://doi.org/10.1074/jbc.272.44.27505" @default.
• W2034685714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9346878" @default.
• W2034685714 hasPublicationYear "1997" @default.
• W2034685714 type Work @default.
• W2034685714 sameAs 2034685714 @default.
• W2034685714 citedByCount "110" @default.
• W2034685714 countsByYear W20346857142012 @default.
• W2034685714 countsByYear W20346857142013 @default.
• W2034685714 countsByYear W20346857142014 @default.
• W2034685714 countsByYear W20346857142015 @default.
• W2034685714 countsByYear W20346857142021 @default.
• W2034685714 countsByYear W20346857142022 @default.
• W2034685714 countsByYear W20346857142023 @default.
• W2034685714 crossrefType "journal-article" @default.
• W2034685714 hasAuthorship W2034685714A5005973308 @default.
• W2034685714 hasAuthorship W2034685714A5087932715 @default.
• W2034685714 hasAuthorship W2034685714A5089377691 @default.
• W2034685714 hasBestOaLocation W20346857141 @default.
• W2034685714 hasConcept C101544691 @default.
• W2034685714 hasConcept C11960822 @default.
• W2034685714 hasConcept C134306372 @default.
• W2034685714 hasConcept C170493617 @default.
• W2034685714 hasConcept C178666793 @default.
• W2034685714 hasConcept C185592680 @default.
• W2034685714 hasConcept C2776165026 @default.
• W2034685714 hasConcept C33923547 @default.
• W2034685714 hasConcept C36503486 @default.
• W2034685714 hasConcept C55493867 @default.
• W2034685714 hasConcept C85528070 @default.
• W2034685714 hasConcept C86803240 @default.
• W2034685714 hasConcept C95444343 @default.
• W2034685714 hasConceptScore W2034685714C101544691 @default.
• W2034685714 hasConceptScore W2034685714C11960822 @default.
• W2034685714 hasConceptScore W2034685714C134306372 @default.
• W2034685714 hasConceptScore W2034685714C170493617 @default.
• W2034685714 hasConceptScore W2034685714C178666793 @default.
• W2034685714 hasConceptScore W2034685714C185592680 @default.
• W2034685714 hasConceptScore W2034685714C2776165026 @default.
• W2034685714 hasConceptScore W2034685714C33923547 @default.
• W2034685714 hasConceptScore W2034685714C36503486 @default.
• W2034685714 hasConceptScore W2034685714C55493867 @default.
• W2034685714 hasConceptScore W2034685714C85528070 @default.
• W2034685714 hasConceptScore W2034685714C86803240 @default.
• W2034685714 hasConceptScore W2034685714C95444343 @default.
• W2034685714 hasIssue "44" @default.
• W2034685714 hasLocation W20346857141 @default.
• W2034685714 hasOpenAccess W2034685714 @default.
• W2034685714 hasPrimaryLocation W20346857141 @default.
• W2034685714 hasRelatedWork W1577635365 @default.
• W2034685714 hasRelatedWork W1593725015 @default.
• W2034685714 hasRelatedWork W1975017809 @default.
• W2034685714 hasRelatedWork W1975526185 @default.
• W2034685714 hasRelatedWork W2027995286 @default.
• W2034685714 hasRelatedWork W2059664212 @default.
• W2034685714 hasRelatedWork W2075557583 @default.
• W2034685714 hasRelatedWork W2089815055 @default.
• W2034685714 hasRelatedWork W2098374005 @default.
• W2034685714 hasRelatedWork W4211215267 @default.
• W2034685714 hasVolume "272" @default.
• W2034685714 isParatext "false" @default.
• W2034685714 isRetracted "false" @default.
• W2034685714 magId "2034685714" @default.
• W2034685714 workType "article" @default.